ArticleAdvances in therapy2025

Population Pharmacokinetics of Niraparib/Abiraterone Acetate Administered as Single-Agent Combination and Dual-Acting Tablets Plus Prednisone for Metastatic Castration-Resistant Prostate Cancer.

Alberto Russu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.